The Enterprise Value as of December 2025 (TTM) for Sprint Bioscience AB (publ) (SPRINT.ST) is 144.16M

According to Sprint Bioscience AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 144.16M. This represents a change of 218.61% compared to the average of 45.25M of the last 4 quarters.

Sprint Bioscience AB (publ) (SPRINT.ST) Historical Enterprise Value (quarterly & annually)

How has SPRINT.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of Sprint Bioscience AB (publ) over the last ten years is 157.36M. The current 144.16M Enterprise Value has changed 9.06% with respect to the historical average. Over the past ten years (40 quarters), SPRINT.ST's Enterprise Value was at its highest in in the June 2016 quarter at 461.53M. The Enterprise Value was at its lowest in in the December 2022 quarter at -3044746.48.

Sprint Bioscience AB (publ) (SPRINT.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Sprint Bioscience AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sprint Bioscience AB (publ) (SPRINT.ST) Average Enterprise Value

How has SPRINT.ST Enterprise Value performed in the past?

The current Enterprise Value of Sprint Bioscience AB (publ) (SPRINT.ST) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Sprint Bioscience AB (publ) (SPRINT.ST) Enterprise Value vs. Peers

How is SPRINT.ST’s Enterprise Value compared to its peers?

Sprint Bioscience AB (publ)’s Enterprise Value is greater than Spago Nanomedical AB (publ) (23.92M), greater than Alligator Bioscience AB (publ) (25.98M), greater than AcouSort AB (publ) (33.91M), greater than SpectraCure AB (publ) (48.35M), greater than Pila Pharma AB (publ) (97.19M), greater than Lipigon Pharmaceuticals AB (publ) (-10658847.00), greater than Simris Alg AB (publ) (139.77M), greater than Active Biotech AB (publ) (50.10M), greater than OncoZenge AB (publ) (74.05M), greater than IDL Diagnostics AB (publ) (65.33M),

Build a custom stock screener for Sprint Bioscience AB (publ) (SPRINT.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sprint Bioscience AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sprint Bioscience AB (publ) (SPRINT.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sprint Bioscience AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.